Adhoc: BioVersys AG: BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

BioVersys AG / Key word(s): Study BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100 29-Oct-2026 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. …

Weiterlesen auf der Quellseite

Ähnliche Beiträge